Amedeo's Top 20

Amedeo Smart

Independent Medical Education

20 June 2022

Multidisciplinary Journal Club

  1. Wang ML, Jurczak W, Jerkeman M, Trotman J, et al.
    Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
    N Engl J Med 2022.

  1. Tie J, Cohen JD, Lahouel K, Lo SN, et al.
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med 2022.

  2. Modi S, Jacot W, Yamashita T, Sohn J, et al.
    Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
    N Engl J Med 2022.

  3. Seth R, Messersmith H, Funchain P.
    Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update.
    J Clin Oncol 2022.

  4. Horsburgh CR, Jo Y, Nichols B, Jenkins HE, et al.
    The contribution of reinfection to annual rate of tuberculosis infection (ARI) and incidence of TB disease.
    Clin Infect Dis 2022.

  1. Ferrante M, Panaccione R, Baert F, Bossuyt P, et al.
    Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
    Lancet 2022;399:2031-2046.

  2. D'Haens G, Panaccione R, Baert F, Bossuyt P, et al.
    Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
    Lancet 2022;399:2015-2030.

  3. Lui DTW, Lee CH, Cheung CYY, Cheung Mak JH, et al.
    Impact of COVID-19 vaccines on thyroid function and autoimmunity and impact of thyroid autoimmunity on antibody response.
    J Clin Endocrinol Metab 2022.

  4. Ghione P, Palomba ML, Patel A, Bobillo S, et al.
    Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
    Blood 2022.

  5. Meersch M, Weiss R, Kullmar M, Bergmann L, et al.
    Effect of Intraoperative Handovers of Anesthesia Care on Mortality, Readmission, or Postoperative Complications Among Adults: The HandiCAP Randomized Clinical Trial.
    JAMA 2022.

  1. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, et al.
    Cannabis-Based Products for Chronic Pain : A Systematic Review.
    Ann Intern Med 2022.

  2. Lipsyc-Sharf M, de Bruin EC, Santos K, McEwen R, et al.
    Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    J Clin Oncol 2022.

  3. Xian J, Parthasarathy S, Ruggiero SM, Balagura G, et al.
    Assessing the landscape of STXBP1-related disorders in 534 individuals.
    Brain 2022;145:1668-1683.

  4. Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, et al.
    Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
    J Clin Oncol 2022;40:1879-1891.

  5. Rossini D, Antoniotti C, Lonardi S, Pietrantonio F, et al.
    Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III
    J Clin Oncol 2022.

  1. Hoybye M, Lind PC, Holmberg MJ, Bolther M, et al.
    Fraction of Inspired Oxygen During General Anesthesia for Non-Cardiac Surgery: Systematic Review and Meta-Analysis.
    Acta Anaesthesiol Scand 2022.

  2. Ueland HO, Ueland GA, Lovas K, Breivik L, et al.
    Novel Inflammatory Biomarkers in Thyroid Eye Disease.
    Eur J Endocrinol 2022.

  3. Laursen LL, Dahl VN, Wejse C.
    Stool testing for pulmonary TB diagnosis in adults.
    Int J Tuberc Lung Dis 2022;26:516-523.

  4. Raballo A, Poletti M, Preti A.
    Do antidepressants prevent transition to psychosis in individuals at clinical high-risk (CHR-P)? Systematic review and meta-analysis.
    Psychol Med 2022.

  5. Borghi C, Agnoletti D, Cicero AFG, Lurbe E, et al.
    Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk.
    Hypertension 2022.


more..

Privacy Policy